Extracorporeal shock wave therapy (ESWT) has become widely preferred in Turkey and worldwide in recent years for the treatment of musculoskeletal diseases due to its non-invasive nature, ease of application, and low risk of complications, as it does not require surgical intervention. However, there is no consensus in the literature regarding the energy level used in ESWT applications, the frequency of application, and especially the ideal number of sessions. Different centers apply varying protocols in clinical practice, which can lead to heterogeneity in treatment outcomes. Scientifically determining the effect of variation in the number of ESWT sessions on clinical outcomes is important for establishing standard treatment protocols. Therefore, the aim of our study is to contribute to the existing literature by investigating the effect of variation in the number of ESWT sessions on clinical parameters such as pain, functional status, and quality of life in the treatment of chronic plantar fasciitis, and to develop more effective and evidence-based treatment approaches in patient management.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Patients aged 18-65, both male and female, diagnosed with plantar fasciitis based on anamnesis and physical examination.
* Patients must have had symptoms for at least 3 months.
* Patients must consent to participate in the study according to the informed consent form.
Exclusion Criteria:
* Complaint lasting less than 3 months
* Having received an injection in the heel area within the last 6 months
* Having applied physical therapy modalities to the heel area within the last 6 months
* Bilateral complaint
* Pregnancy
* Malignancy
* Epilepsy
* History of cardiac pacemaker
* Anticoagulant use
* History of systemic inflammatory disease
* History of fracture or surgery in the lower extremity
* Presence of an open wound in the heel area
* Hypersensitivity in the patient
* Systemic infection in the patient
* Uncontrolled hypertension in the patient
* Uncontrolled diabetes in the patient
* Inability of the patient to cooperate
* History of neuromuscular disease affecting balance parameters
* Patient's unwillingness to participate in the study
Primary outcome measure(s)
Visual Analog Scale — baseline, 3th week, 6th week, 12th week In this scale, pain intensity is generally rated from "absence of pain" (0 points) to "imagined most severe pain" (10 points on a 10-point scale) (Wewers et al., 1990). The pain intensity scoring ranges are: \<3 mild pain, 3-6 moderate pain, \>6 severe pain. VAS is a widely used and practical scale for chronic pain worldwide.
Trial sites (1)
Facility
City
Region
Status
Kırşehir Ahi Evran Training and Research Hospital
Kırşehir
Turkey (Türkiye)
More Kirsehir Ahi Evran Universitesi trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.